Australian (ASX) Stock Market Forum

OSL - Oncosil Medical

With the current good run of SRX, did a bit of googling and came up with "poor man's Sirtex as a spec buy"

SRX has fast growing dose sales and a successful product. OSL is still at least 2-3 years away from selling anything.

I'd call OSL a "homeless man's" Sirtex.
 
oh mannn.......looks like I'm a poor man caught with my pants down then.
:-(

Another one for my pile of bottom drawer collection. ;-\

SuperGlue, I am not dissing it... I have no real insight into the actual prospects of OSL. I am just saying that, at this stage of it's developement relative to SRX, it's more a homeless man than a poor man.

May be this homeless man will turn out to be a millionaire someday... I have no idea really.
 
It's ok.

It was a Spec.buy.

No harm done.

I meant to put my post in a light hearted way.

Another one for my bottom drawer collection. ;-)
with a simle not ;-\


May be this homeless man will turn out to be a millionaire someday...

I won't hold my breath but you've really brighten up my day :)

Looks like I'll be having awesome ribs down at Ribs & Rumps, Fortitude Valley tonight.

Here's to you :bier:
 
It's a pity that tech/a is no longer keeping us updated. I'm sure he would've noticed OSL much sooner ...

OSL n 24-11-15.png

I bought earlier average 17.25; if 18c holds, I reckon 20+ is only days away.
Stop @17c
 
Merry Christmas pixel,
I wanted to acknowledge your early warning of the eventual break-out on OSL. :wreath:
 
Merry Christmas pixel,
I wanted to acknowledge your early warning of the eventual break-out on OSL. :wreath:

Thanks Peter :)

I wish I'd been more patient with this trade. I sold on "time-out" when it fell back again instead of breaking out as planned. I hope you were more successful.

OSL pm 22-12-15.png

In any case, A Merry Christmas to you and your family; and many successful breaks in 2016.

Cheers, Pixel.
 
Oh, I see that last break-out of your box pattern, but you had your focus elsewhere. That's a pity, but it's a common occurrence. We can't trade them all.

As for next year wishes, thanks. I'm excited. It's going to be my best year ever!
 
It's taken a while, but it's starting to look promising again.

OSL am breakout 22-09-17.png

I've taken a small position early; to be added if it breaks resistance.
 
OSL getting ready to have another crack at breaking through 18c? Third time lucky?

big.chart-OSL.gif
 
Disaster for OSL today.

The British Standards Institute "BSI" Clinical Oversight Committee reviewing the OncoSil™ CE Mark file has determined that at this time insufficient clinical benefit has been demonstrated to recommend approval. The Clinical Oversight Committee will now send this recommendation to BSI's Medical Device Group for final determination.

The market reacted swiftly and without mercy following the announcement, sending the share price down to as low as 2.1c. It has since bounced back to 4.9c but that's still a 69.38% decline from Friday's close of 16c.

Ouch! o_O

big.chart-OSL.gif
 
Disaster for OSL today.

The British Standards Institute "BSI" Clinical Oversight Committee reviewing the OncoSil™ CE Mark file has determined that at this time insufficient clinical benefit has been demonstrated to recommend approval. The Clinical Oversight Committee will now send this recommendation to BSI's Medical Device Group for final determination.

The market reacted swiftly and without mercy following the announcement, sending the share price down to as low as 2.1c. It has since bounced back to 4.9c but that's still a 69.38% decline from Friday's close of 16c.

Ouch! o_O

View attachment 93290
That is a shocking news not only for investors but lot many patients waiting to get a happy outcome to their pains. Research wise it also gave a big blow to researchers and alike researches.
 
The long and winding road, to get a Biotech product into the market.
Oncosil, (the product) winding its way, inching its way in the UK toward CE mark for medical devices - as Oncosil is defined.
https://www.asx.com.au/asxpdf/20191101/pdf/44b5yz51tgys6t.pdf

Share price in recent months has regained ground: last close 2nd Jan at $0.16c.

upload_2020-1-3_9-44-58.png


So no reason to expect anything soon, or anything at all. But Biotechs like this if they erupt do so suddenly and spectacularly.
Needless to say, approach with caution, and look carefully.

Regards, P
 
I've picked Oncocil for the Feb tipping competition.
There has been an increase in volume over the last few weeks.
And I like the high volume, high range bar yesterday with a smallish inside bar today.
Hopefully, it will push up past the November high.

OSL.PNG
 
OSL made their first sale last week, hopefully many more to come.

Device is approved for use in the UK, EU, Singapore, Malaysia, NZ . Approval process is underway for China, US, Hong Kong and Aust.

All looking very positive.
 

Attachments

  • 2A1257968_OSL.pdf
    302.8 KB · Views: 5
OSL - looking into various tips were made on OSL beginning of the year and some announcements, I dived into it thinking it is a shallow dive.
The CEO got sacked immediately - no apparent reasons excepting cost reduction on Europe no sale. On a face value, I struggle to accept it considering only recently the ousted CEO got millions of performance rights - which is no good to him. You do not make decisions on awarding performance rights and sacking almost in parallel.
Secondly only a month back the current Chairman and acting CEO bought handsome amount of shares . Did he know what was being hatched which ousted CEO did not know?
If it is part of power politics - that is a bad sign for investors.
purely as a punt put some small money today however on OSL

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4 - CEO TERMINATION IMMEDIATELY

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4 -CEO got performance rights on 5 Nov
https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4 chairman bought good amount on 5 Oct
 
OSL - looking into various tips were made on OSL beginning of the year and some announcements, I dived into it thinking it is a shallow dive.
The CEO got sacked immediately - no apparent reasons excepting cost reduction on Europe no sale. On a face value, I struggle to accept it considering only recently the ousted CEO got millions of performance rights - which is no good to him. You do not make decisions on awarding performance rights and sacking almost in parallel.
Secondly only a month back the current Chairman and acting CEO bought handsome amount of shares . Did he know what was being hatched which ousted CEO did not know?
If it is part of power politics - that is a bad sign for investors.
purely as a punt put some small money today however on OSL

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4 - CEO TERMINATION IMMEDIATELY

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4 -CEO got performance rights on 5 Nov
https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4 chairman bought good amount on 5 Oct
Sacked immediately. Sounds like something dodgy happened.
 
Top